Skyrocketing doxy price gouging shows further action needed
This article was originally published in Scrip
Executive Summary
Doxycycline has been in such short supply in the US that prices for the broad-spectrum antibiotic, which is used to treat and prevent Lyme disease, malaria, acne, sexually transmitted diseases and other infections, have risen astronomically, from just a few dollars to many hundreds of dollars per treatment according to IMS figures and anecdotal reports.